BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 23900077)

  • 1. The evolving epigenome.
    Weichenhan D; Plass C
    Hum Mol Genet; 2013 Oct; 22(R1):R1-6. PubMed ID: 23900077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
    Shu XS; Li L; Tao Q
    Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of non-coding RNAs in epigenetic regulation.
    Chen J; Xue Y
    Sci China Life Sci; 2016 Mar; 59(3):227-35. PubMed ID: 26825947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis.
    Tao H; Yang JJ; Shi KH
    Expert Opin Ther Targets; 2015 May; 19(5):707-16. PubMed ID: 25652534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer epigenome.
    Lechner M; Boshoff C; Beck S
    Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
    Dobosy JR; Fu VX; Desotelle JA; Srinivasan R; Kenowski ML; Almassi N; Weindruch R; Svaren J; Jarrard DF
    Prostate; 2008 Aug; 68(11):1187-95. PubMed ID: 18459101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional regulation of transcription.
    Cao J; Luo Z; Cheng Q; Xu Q; Zhang Y; Wang F; Wu Y; Song X
    Protein Cell; 2015 Apr; 6(4):241-53. PubMed ID: 25670626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.
    Greco CM; Condorelli G
    Nat Rev Cardiol; 2015 Aug; 12(8):488-97. PubMed ID: 25962978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and Cellular Changes During Cancer Progression Resulting From Genetic and Epigenetic Alterations.
    Pruitt K
    Prog Mol Biol Transl Sci; 2016; 144():3-47. PubMed ID: 27865461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and arterial hypertension: the challenge of emerging evidence.
    Friso S; Carvajal CA; Fardella CE; Olivieri O
    Transl Res; 2015 Jan; 165(1):154-65. PubMed ID: 25035152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
    Nowacka-Zawisza M; Wiśnik E
    Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
    Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the function of non-coding RNAs in prostate cancer.
    Ramalho-Carvalho J; Fromm B; Henrique R; Jerónimo C
    Cancer Metastasis Rev; 2016 Jun; 35(2):235-62. PubMed ID: 27221068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.